You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

~ Buy the METACRESOL Drug Excipient Business Development Opportunity Report, 2024 PDF Report in the Report Store ~

Drugs Containing Excipient (Inactive Ingredient) METACRESOL

✉ Email this page to a colleague

« Back to Dashboard

Branded drugs containing METACRESOL excipient, and estimated key patent expiration / generic entry dates

Subscribe to access the full database, or Sign Up
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Eli Lilly and Company	FORTEO	teriparatide	0002-8400	METACRESOL
AstraZeneca Pharmaceuticals LP	BYETTA	exenatide	0310-6512	METACRESOL	2024-11-04
AstraZeneca Pharmaceuticals LP	SYMLINPEN	pramlintide acetate	0310-6615	METACRESOL
Hospira Inc	DEMEROL	meperidine hydrochloride	0409-1181	METACRESOL
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Generic drugs containing METACRESOL excipient

Subscribe to access the full database, or Sign Up
Company	Ingredient	NDC	Excipient
Eli Lilly and Company	insulin lispro	0002-7510	METACRESOL
Eli Lilly and Company	insulin lispro	0002-7511	METACRESOL
Eli Lilly and Company	insulin lispro	0002-7512	METACRESOL
Eli Lilly and Company	insulin glargine	0002-7715	METACRESOL
>Company	>Ingredient	>NDC	>Excipient

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.